GANGAPHARMA (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective August 12, 2025. | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective August 12, 2025.
| |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions, stage movements, and consolidated list effective August … | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions, stage movements, and consolidated list effective August 12, 2025.
| |||||||||||||||
BSE announces movement of securities in and out of Enhanced Surveillance Measure framework with stage changes effective August 12, 2025. | |||||||||||||||
BSE announces movement of securities in and out of Enhanced Surveillance Measure framework with stage changes effective August 12, 2025.
| |||||||||||||||